CEO Harald Schnidar in the B&C Group podcast about protection for innovations and patent rights
In the B&C Group's podcast Über:Mut, Scarletred's CEO Harald Schnidar discusses together with Mariana Karepova, President of the Austrian Patent Office, the protection and potential of innovations in Austria.
SCARLETRED at Round-Table Discussion of Börse Express about Life Science Industry in Austria
In the round table discussion of the leading financial domain Börse Express, Marinomed, Scarletred, PHH Rechtsanwälte, and EOSS Industries discussed the development and hurdles of Austrian life science start-ups.
Epidermolysis Bullosa - How Does Remote Wound Care in Rare Skin Diseases Work?
SCARLETRED’s certified medical device provides medical professionals with a novel digital solution to allow them to assess and analyze the individuals’ affected areas in an accurate, time-efficient, and user-friendly manner.
Scarletred®Vision: A Scalable Digital Solution for Measurement of the Individual Typology Angle (ITA°) and Changes in the Skin Tone
SCARLETRED’s mobile technology, Scarletred®Vision, provides clinically validated R&D tools to document, analyse, and monitor skin color and pigmentation variations in multi-centric or home based cosmetics studies.
Rosacea Objective Standardized Analysis: Quantitative Assessment of Erythema and Skin Texture Alterations
Being a chronic inflammatory skin disorder, patients with rosacea need standardized tools, as provided by SCARLETRED, to improve the condition’s analysis and treatment and overcome psychosocial stigmatization.
The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis